Zaid Matti’s Post

Subacromial injection of platelet-rich plasma provides greater improvement in pain and functional outcomes compared to corticosteroids at 1-year follow-up: a double-blinded randomized controlled trial https://lnkd.in/g-b3gAt7

90s saw the rapid expansion of chromogenic and immunological techniques in #hemostasis, espacially within the #thrombosis panel, for the detection of circulation #anticoagulants, and in D-dimer assays. Check the link below to learn more about history of #Coagulation 👇

Impact of membrane lung induced hypocapnia in veno-arterial #ECMO: 🐀 in vivo model of VA #ECLS using either O2/CO2 mixture vs 100% O2 delivered as sweep gas flow 💨 animals receiving 100% O2 developed significant pCO2 gap & rising blood lactates, inversely proportional to decrease in pCO2 💨 pCO2 gap & lactates similar to pre-ECMO baseline levels in animals receiving O2/CO2 mixture 💨 no significant difference in SvO2 between 2 groups Elevated blood lactates observed in rats receiving 100% O2 may be a response to ML induced hypocapnia/alkaline pH rather than reduced perfusion or underlying tissue hypoxia? ASAIO Journal 🖇️ https://bit.ly/3TjkvbC

From the #Transfusion Evidence Alert: Iron and erythropoietin to heal and recover after intensive care (ITHRIVE): A pilot randomised clinical trial by Litton et al. https://lnkd.in/eQ8i2ti3

From the #Transfusion Evidence Alert: Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial by Porta et al. https://lnkd.in/eDPN-BGr

It's FAQ Friday when we post a Frequently Asked Question about ILC from our website. The answers to these questions were developed with the input of LBCA scientific advisory board members. This week's question is "Does having dense breasts cause ILC?" Read the answer on our FAQ page, Section II, Question #5: https://lnkd.in/eSzUPuMH #LobularBreastCancer #ILCFAQs

#callforreading #recommendations in Methods and Protocols MDPI Title: A Robust and Standardized Approach to Quantify Wound Closure Using the Scratch Assay Authors: Stefan Balko, Evan Kerr, Edward Buchel, Sarvesh Logsetty and Afshin Raouf are from University of Manitoba and CancerCare Manitoba Read and Download for #free at: https://lnkd.in/g-n-fTpA #methods #protocols #scratchassay #wound #keratinocytes #highthroughput #healing #dataset #cells

According to a study recently published in JAMA Network Open, routine polymerase chain reaction (PCR) testing led to faster and more targeted treatment for patients with suspected community-acquired pneumonia in the emergency department.   The random, single-center trial was conducted at Haukeland University Hospital in Bergen, Norway. Results showed people who got rapid PCR tests were more likely to receive pathogen-directed treatment in the first 48 hours post-randomization compared with those receiving standard of care, and in those receiving a pathogen-directed agent in that timeframe, the intervention group received treatment significantly sooner. https://lnkd.in/ddjyckkd #pointofcaretesting

SHIP-CT study is a major milestone clearly demonstrating that imaging-based quantification can precisely assess treatment efficacy. The study was conducted in children with cystic fibrosis, using chest CT as the primary outcome measure. This external validation proves the specificity and high-precision sensitivity of LungQ™ Bronchus-Artery (BA) for an objective quantification of bronchial wall thickening and bronchial widening, as well as its importance for the assessment of a treatment effect. Read the full publication: https://lnkd.in/eQ-7iaq5

Thrilled to share that our abstract, titled “Safety and Efficacy of Antisense Oligonucleotides on Triglyceride and Apolipoprotein C-III Levels in Hypertriglyceridemia: A Network Meta-Analysis of Randomized Controlled Trials,” has been published in Circulation. This research dives into the potential of antisense oligonucleotides to address hypertriglyceridemia by targeting specific pathways, such as triglycerides and apolipoprotein C-III levels. Through a network meta-analysis of RCTs, we aimed to provide insights into the safety and efficacy of these innovative treatment options. You can read the full abstract here: https://lnkd.in/dvgksnF3 #AHA24 #cardiovascularhealth #hypertriglyceridemia #networkmetaanalysis #Circulation